Affirm (AFRM) Insider Executes 10b5-1 Sale, Records Option Acquisitions
Rhea-AI Filing Summary
Affirm Holdings insider Robert O'Hare executed multiple option-related transactions and a sale on 08/22/2025. The filing shows the reporting person acquired stock options or rights covering 20,829; 6,528; 19,857; 8,958; 16,983; and 4,645 shares with exercise prices of $49, $41.80, $17.19, $22.30, $23.35, and $57.59 respectively, with varying vesting schedules. The reporting person sold 77,800 shares on the same date at a weighted average price of $80.09 per share, and the Form 4 reports 0 shares beneficially owned following the sale. The purchases were effected pursuant to a Rule 10b5-1 trading plan adopted December 6, 2024.
Positive
- Transactions effected under a Rule 10b5-1 trading plan, indicating pre-established trading instructions adopted December 6, 2024
- Detailed vesting schedules disclosed for each stock option, providing transparency on future equity alignment
Negative
- Reporting person sold 77,800 Class A shares on 08/22/2025 at a weighted average price of $80.09, resulting in 0 shares beneficially owned
- Significant insider liquidity event that completely divested direct holdings in the issuer
Insights
TL;DR: Insider exercised/received multiple option tranches and completed a sizeable sale leaving zero shares held.
The Form 4 documents contemporaneous option acquisitions and a disposal totaling 77,800 Class A shares sold at a weighted average price of $80.09 per share, leaving the reporting person with zero Class A shares directly beneficially owned. Several stock options were reported acquired with strikes ranging from $17.19 to $57.59 and differing vesting schedules; the filing lists the number of underlying shares attributable to each option and the post-transaction counts. Transactions were executed under a Rule 10b5-1 plan adopted December 6, 2024, which indicates pre-established trading instructions rather than ad hoc sales. For investors, the filing clarifies insider liquidity activity and outstanding option positions but provides no company financial performance data.
TL;DR: Significant insider sale fully divested direct holdings; actions were conducted under a documented 10b5-1 plan.
The report confirms the reporting person executed multiple option-related acquisitions and a single substantial sale on 08/22/2025. The sale reduced direct beneficial ownership to zero and the 10b5-1 plan adoption date is disclosed. The filing includes detailed vesting terms for each option grant, highlighting continued option-based alignment with the company despite the absence of direct share ownership post-sale. This is a material disclosure for governance transparency; it documents compliance with structured trading procedures and provides full vesting schedules for the recorded option grants.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 20,829 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 6,528 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 19,857 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 8,958 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 16,983 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 4,645 | $0.00 | -- |
| Exercise | Class A Common Stock | 20,829 | $49.00 | $1.02M |
| Exercise | Class A Common Stock | 6,528 | $41.80 | $273K |
| Exercise | Class A Common Stock | 19,857 | $17.19 | $341K |
| Exercise | Class A Common Stock | 8,958 | $22.30 | $200K |
| Exercise | Class A Common Stock | 16,983 | $23.35 | $397K |
| Exercise | Class A Common Stock | 4,645 | $57.59 | $268K |
| Sale | Class A Common Stock | 77,800 | $80.09 | $6.23M |
Footnotes (1)
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2024. Represents the weighted average sale price of the shares sold from $80.00 to $80.39 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Stock option vests with respect to 5% of the shares of Class A Common Stock underlying the stock option on the six-month anniversary of January 1, 2021, the vesting commencement date, and the remainder of the grant will vest in quarterly installments over a period of four years, in annual aggregate amounts equal to 15%, 20%, 30% and 30%, respectively, subject to the Reporting Person's continued employment with the Issuer as of each vesting date. The Reporting Person can elect to exercise the stock option at any time, provided that the shares acquired upon exercise remain subject to the applicable vesting schedule. The stock options vest in 48 equal monthly installments beginning April 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. The stock options vest in 48 equal monthly installments beginning August 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. The stock options vest in 48 equal monthly installments beginning October 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. The stock options vest as to 25% of the underlying shares on September 1, 2024 and the remainder vest in 36 equal monthly installments over the subsequent three years subject to the Reporting Person's continuous service with the Issuer as of each vesting date. The stock options vest in 48 equal monthly installments beginning December 1, 2024, subject to the Reporting Person's continuous service with the Issuer as of each vesting date.
